Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001895069 | SCV002156184 | pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2020-11-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with EVC2-related conditions. This variant is present in population databases (rs745404766, ExAC 0.001%). This sequence change creates a premature translational stop signal (p.Gly219*) in the EVC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EVC2 are known to be pathogenic (PMID: 17024374, 19810119, 19876929). |